Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol valerate/dienogest for dysfunctional uterine bleeding
2005-004340-32Phase 3Completed
- Sponsor
- Bayer
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in dysfunctional uterine bleeding (DUB) comparing Estradiol valerate + dienogest with Placebo (2 arms). Primary endpoint: Overall success rate. Started Oct 2005; status: completed.
02
Drugs
estradiol valeratedienogest
03
Conditions
dysfunctional uterine bleeding (DUB)
Beyond the preview
Go deeper on 2005-004340-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004340-32.